November 14, 2019
Practical Law Intellectual Property & Technology
Some experts have called the standards for determining patent eligibility under Section 101 of the Patent Act incoherent. This “incoherence” is particularly challenging for the life sciences industry where certain diagnostic inventions are now unpatentable. In this Q&A, Finnegan attorneys Charles Collins-Chase and Sara Leiman address patent subject matter eligibility, global patent strategies for protecting life sciences inventions, and other legal and regulatory mechanisms to protect life sciences inventions.
Originally printed in Practical Law Intellectual Property & Technology on November 14, 2019. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm's clients.
Workshop
Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law
July 18, 2019
Palo Alto
Workshop
Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law
May 2, 2019
Cambridge
Seminar
Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law
December 5, 2018
Palo Alto
Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is deeply saddened by the death of our colleague Donald R. Dunner, who passed away on October 16, 2019, after a life of dedication and inspiration to many in IP law. Don was in a category all his own with his talent and distinct knowledge of IP law. His direct approach and enthusiasm for work and life touched everyone who worked with him, and we will miss him dearly.